Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXN4LI
|
||||
| Drug Name |
(S)-1-(1H-Indol-4-yloxy)-3-[4-(6-isopropoxy-benzo[b]thiophen-2-yl)-piperidin-1-yl]-propan-2-ol
|
||||
| Synonyms |
CHEMBL301661
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H32N2O3S
|
||||
| Canonical SMILES |
CC(C)Oc1ccc2cc(sc2c1)C3CCN(C[C@H](O)COc4cccc5[nH]ccc45)CC3
|
||||
| InChI |
InChI=1S/C27H32N2O3S/c1-18(2)32-22-7-6-20-14-26(33-27(20)15-22)19-9-12-29(13-10-19)16-21(30)17-31-25-5-3-4-24-23(25)8-11-28-24/h3-8,11,14-15,18-19,21,28,30H,9-10,12-13,16-17H2,1-2H3/t21-/m0/s1
|
||||
| InChIKey |
XRZXDKTYUFAGLZ-NRFANRHFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.